Description
Composition:
Each film-coated bilayer tablet contains:
-
Linagliptin – 2.5 mg
-
Metformin Hydrochloride (as sustained release) – 1000 mg
Dosage Form: Tablet
Route of Administration: Oral
Therapeutic Class:
DPP-4 Inhibitor + Biguanide
Used in the management of type 2 diabetes mellitus to improve glycemic control
Reviews
There are no reviews yet.